European Pharmaceutical Review

MARCH 9, 2023

1 These substances “are pharmacologically and biologically active at low doses,” Dr Kishore Hotha, Global Head of Analytical Research & Development at Veranova, explained. ” Highly potent APIs are pharmacologically and biologically active compounds at low doses. What are the key aspects of HPAPI development?

Safety 90

Safety Pharmacology Training Manufacturing 90

European Pharmaceutical Review

OCTOBER 27, 2022

The report identifies access to talented R&D and CMC personal as the main potential headwinds to market growth – particularly for cell and gene therapy innovators – and predicts an ongoing cooling of China’s bio innovation engine. In the report some 50.4 percent using it in upstream clinical production (up from just 45.0 percent in 2021).

Biopharma 80

Biopharma Manufacturing Pharmacology Training 80

Evolve Your Success

OCTOBER 24, 2023

We would typically engage with Stryker’s engineering, product management, product development, marketing, or even their R&D teams. D oes your team train the sales reps for Stryker , or their training department will handle all of it? W here does the Stryker sales rep for that product interact with the sales rep for you ?

Sales 64

Sales Medical Manufacturing Medical sales 64